About this trial
The aim of this 6-month proof-of-concept study is to map out the chest wall perforators in relation to anatomical landmarks for partial breast reconstruction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing elective breast surgery
Age ≥ 18 years
Female
BMI ≤ 30 kg/m2
Disqualifiers
Pregnant patients
Previous bilateral Breast or axillary surgery
Undergoing bilateral oncoplastic procedure or requiring bilateral pre-operative marking
Undergoing breast surgery requiring pre-operative marking of some of the landmarks and has had contralateral breast or axillary surgery in the past
Trial population
The trial will be carried out at University Hospitals of North Midlands (UHNM). This will be a single centre study. Patients will be screened by the breast surgery Team for the eligibility criteria and recruited from the Breast Outpatients Clinic and marking of the perforators will be carried out on admission unit.
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Location of vesselse
The location of the AICAP vessels in vertical and horizontal axis using constant bony and soft tissue landmarks. This will be measured by the distance of the perforators from the anatomical landmarks
Location of vessels
The location of the MICAP vessels in vertical and horizontal axis using constant bony and soft tissue landmarks. This will be measured by the distance of the perforators from the anatomical landmarks
Location of vessels
The location of the LTAP vessels in vertical and horizontal axis using constant bony and soft tissue landmarks. This will be measured by the distance of the perforators from the anatomical landmarks
Location of vessels
The location of the LICAP vessels in vertical and horizontal axis using constant bony and soft tissue landmarks. This will be measured by the distance of the perforators from the anatomical landmarks
Secondary outcomes
Variability
The degree of variability in location of the perforators.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.